Characterization of folate receptor from normal and neoplastic murine tissue: Influence of dietary folate on folate receptor expression

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1135-1141

  Gates, Susan B ^a   Mendelsohn, Laurane G ^a   Shackelford, Katherine A ^a   Habeck, Lillian L ^a   Kursar, Jonathan D ^a   Gossett, Lynn S ^a   Worzalla, John F ^a   Shih, Chuan ^a   Grindey, Gerald B ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FOLIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL IMMORTALIZATION; CELL METABOLISM; DIETARY INTAKE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; EPITHELIUM CELL; FOLATE METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR AFFINITY;

ANIMALS; CARRIER PROTEINS; FEMALE; FOLIC ACID; HUMANS; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CELL SURFACE;

EID: 0029888122     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lacey, S. W., Sanders, J. M., Rothberg, K. G , Anderson, R. G. W., and Kamen, B. A Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol J. Clin. Invest., 84: 715-720, 1989.
2. Elwood, P. C., Kane, M. A., Portillo, R. M., and Kolhouse, J. F. The isolation, characterization, and comparison of the membrane associated and soluble folate-binding proteins from human KB cells. J. Biol. Chem., 261: 15416-15423, 1986.
3. Antony, A. C., Kane, M A., Portillo, R. M., Elwood, P. C., and Kolhouse, J. F. Studies of the role of a particulate folate-binding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells. J. Biol. Chem., 200: 14911-14917, 1985.
4. Kamen, B. A., Wang, M , Streckfuss, A. J., Peryea, X., and Anderson. R G. W Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J. Biol. Chem., 263: 13602-13609, 1988.
5. Jansen, G , Schornagel, J. H., Westerhof, G. R., Rijksen, G., Newell, D. R., and Jackman, A. L. Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res., 50: 7544-7548, 1990.
6. Pizzorno, G., Cashmore, A. R., Moroson, B. A., Cross, A. D., Smith, A. K., Marling-Cason, M., Kamen, B. A., and Beardsley, G. P. 5,10-dideazatetrahydrofolic acid (DDATHF) transport in CCRF-CEM and MA104 cell lines. J. Biol. Chem. 268: 1017-1023, 1993.
7. Westerhof, G. R., Rijnboutt, S., Schornagel, J H., Pinedo, H. M., Peters, G. J., and Jansen, G. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-1 cells expressing folate-binding protein. Cancer Res., 55: 3795-3802, 1995.
8. Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., and Lacey, S. W. Potocytosis: sequestration and transport of small molecules by caveolae. Science (Washington DC), 255: 410-411, 1992.
9. Willis, S. A., Lacey, S. W., Weitman, S. D., Kamen, B A., and Nisen, P. D. Folate receptor gene expression is tissue-specific and temporally-regulated. Cancer Ther. Control, 2: 223-230, 1992.
10. Shen, F., Ross, J. F., Wang, X., and Ratnam, M. Identification of a novel folate receptor, a truncated receptor, and receptor type β in hematopoietic cells cDNA cloning, expression, immunoreactivity and tissue specificity. Biochemistry, 33: 1209-1215, 1994.
11. Wang, X., Shen, F., Freisheim, J H., Gentry, L. E., and Ratnam, M. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol., 44: 1898-1901, 1992.
12. Ross, J. F., Chaudhuri, P K., and Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer (Phila.), 73: 2432-2443, 1994.
13. Henderson, G. H. Folate-binding proteins. Annu. Rev. Nutr , 10: 319-335, 1990.
14. Bngle, K. E., Westin, E. H., Houghton, M T., and Goldman, I. D. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. J. Biol Chem., 266: 17243-17249, 1991.
15. Brigle, K. E., Spinelia, M. J., Westin, E. H., and Goldman, I. D. Increased expression and characterization of two distinct folate binding proteins in murine erythroteukemia cells. Biochem. Pharmacol., 47: 337-345, 1994.
16. Schmitz, J. C., Grindey, G. B., Schultz, R. M., and Priest, D. G. Impact of dietary folic acid on reduced folates in mouse plasma and tissues: relationship to dideazatetrahydrofolate sensitivity. Biochem Pharmacol., 48: 319-325, 1994.
17. Mendelsohn, L. G., Gates, S. B., Habeck, L. L., Shackelford, K. A , Worzalla, J. F., Shih, C., and Grindey, G. B. The role of dietary folate in modulation of folate receptor expression, folylpolyglutamate synthetase activity and the efficacy and toxicity of lometrexol. In: G. Weber (ed.), Advances in Enzyme Regulation, Vol. 35. Great Britain: Pergamon, in press, 1996.
18. Alan, T., Worzalla, J. F , Shih, C., Bewley, J. R., Lewis, S., Moran, R. G., and Grindey, G. B. Augmentation of the therapeutic activity of lometrexol [(6R)5,10-dideazatetrahydrofolate) by oral folic acid. Cancer Res., 56: 2331-2335, 1996
19. Wedge, S R., Laohavinji, S., Taylor, G. A., Boddy, A., Calvert, A. H., and Newell, D. R. Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10-dideazatetrahydrofolic acid (lometrexol) administered with an oral folic acid supplement. Clin. Cancer Res., 1: 1479-1486, 1995.
20. Beardsley, G. P., Moroson, B A., Taylor, E. C., and Moran, R. G. A new folate antimetabolitc, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis J. Biol. Chem., 264: 328-333, 1989.
21. Jackman, A. L., Taylor, G. A., Gibson, W , Kimbell, R., Brown, M., Calvert, A. H., Judson, I R., and Hughes, L. R ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res , 51: 5579-5586, 1991.
22. Antony, A. C., Kincade, R. S., Verma, R. S , and Krishnan, S. R. Identification of high affinity folate binding proteins in human erythrocyte membranes. J. Clin. Invest., 80. 711-723, 1987.
23. 2F receptor. Mol. Pharmacol., 43: 419-426, 1993.
24. so) of an enzymatic reaction. Biochem. Pharmacol., 22: 3099-3108, 1973.
25. Crouse, G. F., Simonsen, C. C., McEwen, R. N., and Schimke, R. T. Structure of amplified normal and variant dihydrofolate reductase genes in mouse sarcoma S180 cells. J. Biol. Chem., 257: 558-564, 1988.
26. Faust, P. L., Kornfeld, S., and Chirgwin, J. M. Cloning and sequence analysis of cDNA for human cathepsin D Proc. Natl. Acad. Sci USA, 82: 4910-4914, 1985.
27. Lark, R. H., Smith, A. K., and Kamen, B. A. Should patients receiving anti-folates be treated with folic acid first? A rationale based upon studies of folylpolyglutamate synthetase. Cancer Res. Ther. Con-trol, 4: 11-16, 1994.
28. Browman, G. P., Goodyear. M. D. E., Levine, M. N., Russell, R., Archibald, S.D., and Young, J. E. M. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial. J. Clin. Oncol., 8: 203-208, 1990.
29. Moertel, C. G., Fleming, T. R., MacDonald, J. S., Haller, D G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., Veeder, M. H., and Mailliard, J. A. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J Med., 322: 352-358, 1990.
30. Henderson, G. B., Tsuji, J. M., and Kumar, H. P. Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folate. J Membr Biol., 101: 247-258, 1988.
31. Kane, M. A., Elwood, P. C., Portillo, R. M., Antony, A. C., Najfeld, V., Finley, A., Waxman, S., and Kolhouse, J. F. Influence on immunoreactive folate-binding proteins of extracellular folate concentration in cultured human cells. J. Clin. Invest., 81: 1398-1406, 1988.
32. Kamen, B. A., and Capdevila, A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Proc. Natl. Acad. Sci USA. 83: 5983-5987, 1986.
33. McMartin, K. E., Collins, T. D., Eisenga, B. H., Fortney, T , Bates, W. R., and Bairnsfather, L. Effects of chronic ethanol and diet treatment on urinary folate excretion and development of folate deficiency in the rat. J. Nutr., 119: 1490-1497, 1989.
34. da Costa, M., and Rothenberg, S. P. Characterization of folate-binding proteins associated with the plasma membrane of rat liver. Biochim. Biophys. Acta, 939. 533-541, 1988.
35. Ward, G J., and Nixon, P. F. Modulation of pteroylpolyglutamate concentration and length in response to altered folate nutrition in a comprehensive range of rat tissues. J. Nutr., 120: 476-484, 1990.
36. 12 in patients with malignant hematologic diseases. Cancer Res., 25: 1933-1938, 1965.
37. Einhorn, J., and Reizenstein, P. Metabolic studies on folic acid in malignancy. Cancer Res , 26: 340-343, 1966.
38. Saleh, A. M., Pheasant, A. E., Blair, J. A., Allan. R. N., and Walters, J. Folate metabolism in man: The effect of malignant disease. Br. J. Cancer, 46: 346-353, 1982.
39. Ray, M. S., Muggia, F. M., Leichman, C G., Grunberg, S. M., Nelson, R. L., Dyke, R. W., and Moran, R. G. Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J. Natl. Cancer Inst., 85: 1154-1159, 1993